EuroPCR 2022 | The MITRA TUNE Registry

Left atrial enlargement with or without atrial fibrillation (AF), absence of valvular degeneration, and heart failure with preserved function have recently been identified as functional atrial mitral regurgitation (MR). This subtype of secondary MR currently appears to be underdiagnosed, and the need for treatment in the general population might be greater than predicted.

The MITRA TUNE Registry

The aim of this multicenter study was to analyze the 30-day and 2-year clinical and echocardiographic outcomes of patients who underwent transcatheter mitral valve repair.

Inclusion criteria were functional mitral insufficiency 3+/4+, LV diastolic diameter <55 without motility disorders; persistent, permanent, or paroxysmal AF, and normal valvular structure. 

Of the 1135 patients, 87 met the inclusion criteria. Mean patient age was 81 years old, and most subjects were female (61%). The Society of Thoracic Surgeons (STS) score was 4%. Technical success was 97%. The in-hospital death rate was 2%, the acute renal failure rate was 8%, and the major bleeding rate was 4.5%. At 30 days, the total mortality rate was 5% and the rate for cardiovascular death was 4%.

Mild or moderate MR was present in 98% of patients, and symptomatic improvement was observed in 79% of patients with functional class I/II within the first year of follow-up.

Echocardiographic analysis of the left atrium showed significant positive remodeling compared with baseline values and control outcomes within the first year. 

Read also: DISCO RADIAL: Conventional or Distal Transradial Access?

The rate for cardiovascular survival and hospitalization for heart failure in these patients was 55% at 2 years. A multivariate analysis showed that postprocedural MI ≥2+ and intercommissural annular diameter ≥35 mm were independent negative predictors.

Conclusion

In patients with functional atrial MR, transcatheter edge-to-edge repair of the mitral valve was shown to be safe and effective, inducing positive reverse remodeling of the left atrium and mitral annulus, improving symptoms.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez
Member of the Editorial Board of SOLACI.org.

Original Title: MItraClip in Atrial Functional mitral regurgitation: a multi-center experience. The MITRA TUNE Registry. 

Reference: Antonio Popolo Rubbio, et al. EUROPCR.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...